AR coactivators, CBP/p300, are critical mediators of DNA repair in prostate cancer
Sumaira Sardar, Christopher M. McNair, Lakshmi Ravindranath, Saswati N. Chand, Wei Yuan, Denisa Bogdan, Jon C. Welti, Adam Sharp, Natalie K. Ryan, Liam A Knudsen, Matthew Joseph Schiewer, Elise G. DeArment, Thomas Janas, Xiaofeng A. Su, Lisa M. Butler, , Ayesha A. Shafi
This study identifies CBP/p300 as critical for DNA repair in prostate cancer and shows that targeting it enhances therapeutic response.
Oncogene · Sep 12, 2024Peer-reviewedCancer Biology